Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-13-059926
Filing Date
2013-08-05
Accepted
2013-08-05 17:26:07
Documents
2
Period of Report
2013-08-01

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3643
2 EX-24 ex-24.htm EX-24 11056
  Complete submission text file 0001104659-13-059926.txt   16025
Mailing Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 440 CAMBRIDGE MA 02142 617-252-9300
Verastem, Inc. (Issuer) CIK: 0001526119 (see all company filings)

EIN.: 273269467 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 215 FIRST STREET, SUITE 440 CAMBRIDGE MA 02142
Business Address
Pachter Jonathan (Reporting) CIK: 0001540410 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35403 | Film No.: 131011119